Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

about

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

Item

http://www.wikidata.org/entity/Q39028122

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@en

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@nl

type

Item

label

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@en

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@nl

prefLabel

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@en

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@nl

P1476

Direct Oral Anticoagulants: An Overview for the Interventional Radiologist.

@en

P2093

Caroline Shiach

http://www.w3.org/2001/XMLSchema#string

Gaurav Sundar

http://www.w3.org/2001/XMLSchema#string

Pradesh Kumar

http://www.w3.org/2001/XMLSchema#string

Rajeev Ravi

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Apixaban metabolism and pharmacokinetics after oral administration to humans.

Triggers, targets and treatments for thrombosis.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

P2888

s00270-016-1521-0

P304

321-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00270-016-1521-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27913856

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation